This topic contains a solution. Click here to go to the answer

Author Question: When digitally recording an interview with a witness, which of the following information should not ... (Read 35 times)

SGallaher96

  • Hero Member
  • *****
  • Posts: 509
When digitally recording an interview with a witness, which of the following information should not be included at the beginning of the recording?
 
  a. The name of the person being interviewed
  b. The name of the person conducting the interview
  c. The date, time, and place of the interview
  d. The interviewer's social security number

Question 2

Which of the following is generally true about witness statements?
 
  a. They should not be approved by the supervising attorney
  b. They usually cannot be introduced as evidence
  c. They are very time-consuming to create and should be avoided
  d. None of these choices are correct



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

moormoney

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

D

Answer to Question 2

B




SGallaher96

  • Member
  • Posts: 509
Reply 2 on: Aug 3, 2018
Gracias!


EAN94

  • Member
  • Posts: 307
Reply 3 on: Yesterday
Excellent

 

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Anti-aging claims should not ever be believed. There is no supplement, medication, or any other substance that has been proven to slow or stop the aging process.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library